MedPath

A Study of Teduglutide in Japanese People with Short Bowel Syndrome

Not Applicable
Recruiting
Conditions
Short Bowel Syndrome
Registration Number
JPRN-jRCT2031210284
Lead Sponsor
Contact for Clinical Trial Information
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

All participants in Japan who received teduglutide will be enrolled in this post marketing surveillance.

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath